The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 08, 2022
Filed:
Aug. 31, 2018
Applicants:
Mitsubishi Tanabe Pharma Corporation, Osaka, JP;
Hyogo College of Medicine, Nishinomiya, JP;
Inventors:
Tomohiro Yoshimoto, Nishinomiya, JP;
Joseph M. Palumbo, Jersey City, NJ (US);
Violetta I. Stone, Lebanon, NJ (US);
Toru Kato, Nishinomiya, JP;
Koubun Yasuda, Nishinomiya, JP;
Assignees:
MITSUBISHI TANABE PHARMA CORPORATION, Osaka, JP;
HYOGO COLLEGE OF MEDICINE, Nishinomiya, JP;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/24 (2006.01); A61K 39/395 (2006.01); A61K 38/17 (2006.01);
U.S. Cl.
CPC ...
C07K 16/244 (2013.01); A61K 39/395 (2013.01); C07K 2317/76 (2013.01);
Abstract
Based on the identification of IL-33 as an exacerbating factor in endometriosis and adenomyosis uteri, a therapeutic agent for endometriosis and adenomyosis uteri has an IL-33 antagonist, which is capable of inhibiting the function of IL-33. The IL-33 antagonist is useful for treating, preventing or alleviating endometriosis and uterine adenomyosis uteri.